Drug:
Reaction: COVID-19
20250101 - 20251231
No. 1 - 100
| No. | safetyreportid |
occurcountry |
patientonsetage |
patientsex 1:M 2:F |
|---|---|---|---|---|
Adverse reaction |
||||
Drug (openfda.generic_name, medicinalproduct) |
||||
| 1 | 25491724 |
US |
41 | 1 |
COVID-19, Migraine, Off label use, |
||||
GALCANEZUMAB-GNLM, |
||||
| 2 | 25491766 |
US |
2 | |
COVID-19, Sinusitis, Multiple allergies, |
||||
| 3 | 25491893 |
US |
38 | 1 |
Atrial fibrillation, COVID-19, Feeling abnormal, Sinusitis, Sinus congestion, Respiratory tract infection, Infusion site rash, Incorrect drug administration rate, Infusion site bruising, Hypersensitivity, Infusion site erythema, Infusion site swelling, Infusion site pain, Infusion site discomfort, |
||||
DIPHENHYDRAMINE, DIPHENHYDRAMINE HYDROCHLORIDE, EPINEPHRINE, ADRENALINUM, BUPROPION HYDROCHLORIDE, BISOPROLOL FUMARATE, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, CELECOXIB, MOMETASONE FUROATE, MOMETASONE, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, OLMESARTAN MEDOXOMIL, AZELASTINE HYDROCHLORIDE, AZELASTINE, SODIUM CHLORIDE, SODIUM CHLORIDE INJECTION, SODIUM CHLORIDE TABLET, ALPRAZOLAM, MODAFINIL, SULFAMETHOXAZOLE AND TRIMETHOPRIM, LEVOCETIRIZINE DIHYDROCHLORIDE, ESZOPICLONE, LIDOCAINE, LIDOCAINE HYDROCHLORIDE, BURN RELIEF, MAXIMUM STRENGTH PAIN RELIEVER, LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE BITARTRATE, LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE, LIDOCAINE 4%, LIDOCAINE, MENTHOL, VILAZODONE HYDROCHLORIDE, ZOLEDRONIC ACID, ERGOCALCIFEROL, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, LORATADINE, PSEUDOEPHEDRINE SULFATE, FLUTICASONE PROPIONATE, CARISOPRODOL, DIPHENHYDRAMINE HYDROCHLORIDE, DIPHENHYDRAMINE HYDROCHLORIDE CAPSULE, LIQUID FILLED, GLIMEPIRIDE, |
||||
| 4 | 25492706 |
PL |
||
COVID-19, |
||||
ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, PSEUDOEPHEDRINE HYDROCHLORIDE, PSEUDOEPHEDRINE HCL, DEXTROMETHORPHAN, HALOPERIDOL, HALOPERIDOL LACTATE, |
||||
| 5 | 25492730 |
TH |
2 | |
COVID-19, |
||||
MACITENTAN, |
||||
| 6 | 25492747 |
US |
2 | |
Kidney infection, Device infusion issue, Somnolence, Inappropriate schedule of product administration, Memory impairment, Muscular weakness, Oropharyngeal pain, Infusion site mass, Migraine, Hypersensitivity, COVID-19, Illness, Wrong technique in product usage process, Abdominal discomfort, Malaise, Fatigue, |
||||
| 7 | 25492862 |
US |
76 | 1 |
COVID-19, Off label use, |
||||
POMALIDOMIDE, |
||||
| 8 | 25493615 |
US |
69 | 1 |
Needle issue, Device issue, COVID-19, |
||||
ABATACEPT, |
||||
| 9 | 25493632 |
GB |
27 | 2 |
Haemophagocytic lymphohistiocytosis, COVID-19, Off label use, |
||||
METHOTREXATE, METHOTREXATE SODIUM, PREDNISONE, PIPERACILLIN SODIUM,TAZOBACTAM SODIUM, METHYLPREDNISOLONE, |
||||
| 10 | 25494503 |
CA |
97 | 2 |
Acute kidney injury, COVID-19, Cholangitis, General physical health deterioration, Hepatitis, Jaundice, Septic shock, |
||||
REMDESIVIR, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, AZITHROMYCIN, AZITHROMYCIN MONOHYDRATE, AZITHROMYCIN DIHYDRATE, BISOPROLOL FUMARATE, CEFTRIAXONE, CEFTRIAXONE SODIUM, FUROSEMIDE, OXAZEPAM, PIPERACILLIN SODIUM,TAZOBACTAM SODIUM, |
||||
| 11 | 25494554 |
CA |
80 | 2 |
Pruritus, Diarrhoea, Vomiting, Urinary tract infection, COVID-19, Depression, Taste disorder, Vision blurred, Dyspnoea, Anxiety, Malaise, Somnolence, Headache, Productive cough, Dry eye, Skin exfoliation, Pain in extremity, Asthenia, Fatigue, Decreased appetite, Weight increased, Weight decreased, Dizziness, Balance disorder, Blood culture positive, Pyrexia, |
||||
| 12 | 25494880 |
US |
57 | 2 |
COVID-19, |
||||
NIRMATRELVIR AND RITONAVIR, FLUOXETINE HYDROCHLORIDE, FLUOXETINE, LORATADINE, LORATADINE TABLET, |
||||
| 13 | 25494957 |
US |
32 | 2 |
COVID-19, |
||||
IXEKIZUMAB, IXEKIZUMAB, IXEKIZUMAB, IXEKIZUMAB, |
||||
| 14 | 25495208 |
CA |
54 | 2 |
Condition aggravated, Thrombosis, COVID-19, Off label use, |
||||
RITUXIMAB-PVVR, RITUXIMAB-PVVR, |
||||
| 15 | 25495374 |
CA |
49 | 2 |
Haematochezia, Off label use, Bronchitis, Terminal ileitis, Arthropathy, Dyspepsia, COVID-19, Emotional disorder, Viral infection, Constipation, Condition aggravated, |
||||
METHOTREXATE SODIUM, PANTOPRAZOLE, PREDNISONE, |
||||
| 16 | 25495423 |
CA |
35 | 2 |
Diabetes mellitus, COVID-19, Rheumatoid arthritis, Autoimmune thyroiditis, Gastrointestinal disorder, Therapeutic product effect decreased, |
||||
METHOTREXATE SODIUM, HYDROXYCHLOROQUINE SULFATE, ETANERCEPT, |
||||
| 17 | 25495640 |
US |
88 | 1 |
COVID-19, Disease recurrence, |
||||
NIRMATRELVIR AND RITONAVIR, |
||||
| 18 | 25495670 |
US |
60 | 1 |
COVID-19, Eczema, Pruritus, |
||||
DUPILUMAB, FLUTICASONE PROPIONATE, LEVOCETIRIZINE DIHYDROCHLORIDE, MONTELUKAST SODIUM, MONTELUKAST, MOMETASONE FUROATE AND FORMOTEROL FUMARATE DIHYDRATE, |
||||
| 19 | 25496081 |
JP |
66 | 2 |
COVID-19, Chronic kidney disease, |
||||
ROZANOLIXIZUMAB, |
||||
| 20 | 25496190 |
CO |
54 | 2 |
Septic shock, COVID-19, Pseudomonas infection, Mucormycosis, Mucormycosis, Enterococcal infection, Enterobacter infection, Stenotrophomonas infection, Staphylococcal infection, Streptococcal infection, Off label use, Incorrect dose administered, |
||||
TACROLIMUS, TACROLIMUS OINTMENT 0.1%, TACROLIMUS EXTENDED-RELEASE CAPSULES, MYCOPHENOLIC ACID, MYCOPHENILIC ACID, PREDNISOLONE, PREDNISOLONE ORAL, PREDNISOLONE ORAL SOLUTION, PREDNISOLONE, PREDNISOLONE ORAL, PREDNISOLONE ORAL SOLUTION, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, GEMFIBROZIL, |
||||
| 21 | 25496195 |
US |
64 | |
COVID-19, Disease recurrence, |
||||
NIRMATRELVIR AND RITONAVIR, LOSARTAN, |
||||
| 22 | 25496639 |
US |
56 | 1 |
COVID-19, Neuroleptic malignant syndrome, |
||||
ARIPIPRAZOLE ORALLY DISINTEGRATING, ARIPIPRAZOLE, ARIPIPRAZOLE ORAL, CLOZAPINE, CLOZAPINE, |
||||
| 23 | 25496645 |
US |
46 | 2 |
Neuroleptic malignant syndrome, COVID-19, |
||||
RISPERIDONE, RISPERIDONE, CLOZAPINE, CLOZAPINE, |
||||
| 24 | 25499800 |
39 | 2 | |
COVID-19, General physical health deterioration, Suicidal ideation, Failure to thrive, Fatigue, Malaise, Dysphagia, Decreased appetite, Weight decreased, Dry mouth, Dysphonia, Anxiety, Heart rate increased, Insomnia, Malnutrition, Illness, Withdrawal syndrome, Panic attack, |
||||
CALCIUM, MAGNESIUM, POTASSIUM, AND SODIUM OXYBATES, SERTRALINE, METHYLPHENIDATE, METHYLPHENIDATE HYDROCHLORIDE, |
||||
| 25 | 25491034 |
US |
38 | 2 |
COVID-19, |
||||
DUPILUMAB, |
||||
| 26 | 25491132 |
AU |
56 | 2 |
Anaphylactic reaction, Respiratory failure, Mast cell activation syndrome, Pneumonia, Pneumonia haemophilus, Human rhinovirus test positive, Upper respiratory tract infection, Respiratory syncytial virus test positive, COVID-19, Mouth haemorrhage, Tongue biting, Viral test positive, |
||||
ANASTROZOLE, ANASTROZOLE TABLETS, MONTELUKAST, ROSUVASTATIN CALCIUM, APIXABAN, ESOMEPRAZOLE MAGNESIUM, ESOMEPRAZOLE, ESOMEPRAZOLE MAGNESIUM CAPSULE, DELAYED RELEASE, ESOMEPRAZOLE MAGNESIUM DELAYED RELEASE CAPSULES, FAMOTIDINE, INSULIN GLARGINE-YFGN, INSULIN GLARGINE, LORATADINE, LORATADINE ORAL, METFORMIN HYDROCHLORIDE, METFORMIN, METFORMIN HYDROCHLORIDE EXTENDED-RELEASE TABLETS, METFORMIN HYDROCHLORIDE TABLET, METFORMIN HYDROCHLORIDE TABLETS, PROMETHAZINE HYDROCHLORIDE, PROMETHAZINE, ALBUTEROL SULFATE, |
||||
| 27 | 25489946 |
CA |
37 | 2 |
Angioedema, Dyspnoea, Middle insomnia, Pyelonephritis, Rash, Visual impairment, Blood pressure increased, Exposure to SARS-CoV-2, Pain, Therapy partial responder, Oedema peripheral, Oropharyngeal pain, Infection, Mechanical urticaria, Peripheral swelling, Pruritus, Skin reaction, Weight decreased, Arthralgia, Bronchitis, Chronic sinusitis, Diarrhoea, Generalised oedema, Injection site extravasation, COVID-19, Pneumonia, Pyrexia, Temperature intolerance, Urticaria, Addison^s disease, Autoimmune hepatitis, Drug ineffective, Fatigue, Haematemesis, Heart rate increased, Palpitations, Tuberculosis, Chest discomfort, Erythema, Nausea, |
||||
METHOTREXATE, METHOTREXATE SODIUM, INFLIXIMAB, REPAGLINIDE, ETANERCEPT, KETOTIFEN FUMARATE, METOPROLOL TARTRATE, METOROPROLOL TARTRATE, METOPROLOL, OMALIZUMAB, APREMILAST, OMALIZUMAB, OMALIZUMAB, |
||||
| 28 | 25490002 |
CA |
||
Unevaluable event, COVID-19, |
||||
INFLIXIMAB-DYYB, |
||||
| 29 | 25490250 |
CA |
2 | |
Pulmonary fibrosis, Infusion site reaction, Mite allergy, Mechanical urticaria, Chronic sinusitis, COVID-19, Atelectasis, Pain, Erythema, Pruritus, Fatigue, |
||||
HUMAN IMMUNOGLOBULIN G, HUMAN IMMUNOGLOBULIN G, METOPROLOL TARTRATE, METOPROLOL, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, MOMETASONE FUROATE, MOMETASONE, GUAIFENESIN, RIVAROXABAN, CYCLOSPORINE, PREGABALIN, LIRAGLUTIDE, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CONTINUOUS SPRAY, ANTI-PRURITIC, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, HYDROCORTISONE LOTION KIT, ANTI ITCH, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE CREAM 1%, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, RIVAROXABAN, PROGESTERONE, ESTRADIOL, ESTRADIOL GEL 0.1%, ESTRADIOL TRANSDERMAL, ESTRADIOL,, NALTREXONE HYDROCHLORIDE AND BUPROPION HYDROCHLORIDE, |
||||
| 30 | 25490927 |
US |
2 | |
COVID-19, Brain fog, Dermatitis atopic, Drug effect less than expected, Product dose omission in error, |
||||
DUPILUMAB, FLUOXETINE HYDROCHLORIDE, HYDROXYZINE, LAMOTRIGINE, LAMOTRIGINE EXTENDED-RELEASE, LAMOTRIGINE CHEWABLE DISPERSIBLE, LAMOTIRIGINE, NAPROXEN, NAPROXEN SODIUM, PROPRANOLOL HYDROCHLORIDE, ROSUVASTATIN, VALACYCLOVIR HYDROCHLORIDE, VALACYCLOVIR, |
||||
| 31 | 25486425 |
US |
57 | 2 |
Dyspnoea exertional, Chills, COVID-19, Asthma, |
||||
DENOSUMAB, |
||||
| 32 | 25486588 |
US |
2 | |
Thyroid mass, Thyroxine decreased, Respiratory failure, Injection site pain, Fatigue, Upper respiratory tract infection, Injection site bruising, COVID-19, Hypersensitivity, |
||||
BIMEKIZUMAB, IRON, FREMANEZUMAB-VFRM, SECUKINUMAB, |
||||
| 33 | 25486752 |
GB |
54 | 1 |
Neuropathy peripheral, Toothache, Urinary bladder haemorrhage, Lethargy, Trigeminal neuralgia, Hepatic function abnormal, Electric shock sensation, Tinnitus, Mental impairment, Immunosuppression, Hypothyroidism, Photophobia, Spinal pain, Lip swelling, Blindness, Brain fog, Gait disturbance, Pain in extremity, Suicidal ideation, Mouth swelling, Punctate keratitis, Facial pain, Hyponatraemia, Somnolence, Dyspnoea, Pyrexia, Feeling of despair, White blood cell disorder, Depression, Confusional state, Dizziness, Nausea, Amnesia, COVID-19, Headache, Urinary tract infection, Haematological infection, Cough, Paraesthesia, Carpal tunnel syndrome, Dry eye, Hypoaesthesia, Influenza like illness, Flushing, Anxiety, Rash vesicular, Chest pain, |
||||
PREDNISOLONE, PREDNISOLONE ORAL, PREDNISOLONE ORAL SOLUTION, PREDNISOLONE, PREDNISOLONE ORAL, PREDNISOLONE ORAL SOLUTION, PREGABALIN, PREGABALIN, PREGABALIN, PREGABALIN, PREGABALIN, PREGABALIN, OXCARBAZEPINE, OXYCODONE HYDROCHLORIDE, OXYCODONE, EPTINEZUMAB-JJMR, PREDNISOLONE, PREDNISOLONE ORAL, PREDNISOLONE ORAL SOLUTION, CARBAMAZEPINE, CARBAMAZEPINE, BACLOFEN, BACLOFEN, PHENYTOIN, PHENYTOIN, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, LAMOTRIGINE, LAMOTRIGINE EXTENDED-RELEASE, LAMOTRIGINE CHEWABLE DISPERSIBLE, LAMOTIRIGINE, LAMOTRIGINE, LAMOTRIGINE EXTENDED-RELEASE, LAMOTRIGINE CHEWABLE DISPERSIBLE, LAMOTIRIGINE, LAMOTRIGINE, LAMOTRIGINE EXTENDED-RELEASE, LAMOTRIGINE CHEWABLE DISPERSIBLE, LAMOTIRIGINE, LAMOTRIGINE, LAMOTRIGINE EXTENDED-RELEASE, LAMOTRIGINE CHEWABLE DISPERSIBLE, LAMOTIRIGINE, LAMOTRIGINE, LAMOTRIGINE EXTENDED-RELEASE, LAMOTRIGINE CHEWABLE DISPERSIBLE, LAMOTIRIGINE, LAMOTRIGINE, LAMOTRIGINE EXTENDED-RELEASE, LAMOTRIGINE CHEWABLE DISPERSIBLE, LAMOTIRIGINE, LAMOTRIGINE, LAMOTRIGINE EXTENDED-RELEASE, LAMOTRIGINE CHEWABLE DISPERSIBLE, LAMOTIRIGINE, LAMOTRIGINE, LAMOTRIGINE EXTENDED-RELEASE, LAMOTRIGINE CHEWABLE DISPERSIBLE, LAMOTIRIGINE, MIRTAZAPINE, BUPRENORPHINE, NALTREXONE, NAPROXEN, NAPROXEN SODIUM, ONDANSETRON HYDROCHLORIDE, ONDANSETRON, ONDANSETRON TABLETS, LACOSAMIDE, LACOSAMIDE, LACOSAMIDE, LACOSAMIDE, LACOSAMIDE, DIAZEPAM, DIAZEPAM ORAL, DIAZEPAM ORAL SOLUTION (CONCENTRATE), DULOXETINE HYDROCHLORIDE, DULOXETINE, DULOXETINE HYDROCHLORIDE, DULOXETINE, ACYCLOVIR, ONABOTULINUMTOXINA, LIDOCAINE, LIDOCAINE HYDROCHLORIDE, BURN RELIEF, MAXIMUM STRENGTH PAIN RELIEVER, LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE BITARTRATE, LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE, LIDOCAINE 4%, LIDOCAINE, MENTHOL, LIDOCAINE, LIDOCAINE HYDROCHLORIDE, BURN RELIEF, MAXIMUM STRENGTH PAIN RELIEVER, LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE BITARTRATE, LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE, LIDOCAINE 4%, LIDOCAINE, MENTHOL, MAGNESIUM, GABAPENTIN, GABAPENTIN, GABAPENTIN, |
||||
| 34 | 25486785 |
US |
77 | 2 |
Sepsis, COVID-19, Pyrexia, Dyspnoea, |
||||
DUPILUMAB, |
||||
| 35 | 25486951 |
CA |
||
Condition aggravated, COVID-19, Influenza, Illness, Immune system disorder, Sinusitis, |
||||
INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, CELECOXIB, DEXLANSOPRAZOLE, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, |
||||
| 36 | 25487037 |
CA |
62 | 1 |
Pneumonia, COVID-19, |
||||
RISANKIZUMAB-RZAA, PREDNISONE, UPADACITINIB, |
||||
| 37 | 25487096 |
GB |
69 | 2 |
Acute kidney injury, Overdose, Polyuria, Hypotension, International normalised ratio abnormal, Dialysis, Medication error, Amnesia, Abdominal pain upper, Nausea, Blindness, Abdominal discomfort, Tinnitus, Palmoplantar keratoderma, Atrial tachycardia, Dry skin, Immunisation, Tension headache, Alopecia, Diarrhoea, Angioedema, Headache, Hallucination, COVID-19, Dizziness, Arthralgia, Pain of skin, Peripheral swelling, Disturbance in attention, Cognitive disorder, Memory impairment, Visual impairment, Diplopia, Vasculitis, Carotid artery occlusion, Transient ischaemic attack, Pruritus genital, Subarachnoid haemorrhage, Sleep terror, Vomiting, Ventricular tachycardia, Pericarditis, Cardiospasm, Dyspnoea, Fatigue, Anxiety, Muscular weakness, Feeling abnormal, Insomnia, Heart rate increased, Blood glucose increased, Muscle twitching, Dehydration, Pyrexia, Hyperhidrosis, Chest pain, Back pain, Rash, Lip swelling, Pruritus, Myocardial infarction, Palpitations, Tachycardia, Pain, Anosmia, Eye pruritus, Facial pain, Migraine, Malaise, Intentional product use issue, Intentional product misuse, Incorrect product administration duration, Medication error, Off label use, |
||||
OLANZAPINE, OLANZAPINE, OLANZAPINE, ESOMEPRAZOLE MAGNESIUM, ESOMEPRAZOLE, ESOMEPRAZOLE MAGNESIUM CAPSULE, DELAYED RELEASE, ESOMEPRAZOLE MAGNESIUM DELAYED RELEASE CAPSULES, ARIPIPRAZOLE, ARIPIPRAZOLE, LITHIUM CARBONATE, LITHIUM CARBONATE, LITHIUM CARBONATE, LITHIUM CARBONATE, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, WARFARIN, METFORMIN HYDROCHLORIDE, METFORMIN, METFORMIN HYDROCHLORIDE EXTENDED-RELEASE TABLETS, METFORMIN HYDROCHLORIDE TABLET, METFORMIN HYDROCHLORIDE TABLETS, METFORMIN HYDROCHLORIDE, METFORMIN, METFORMIN HYDROCHLORIDE EXTENDED-RELEASE TABLETS, METFORMIN HYDROCHLORIDE TABLET, METFORMIN HYDROCHLORIDE TABLETS, WARFARIN SODIUM, WARFARIN, ARIPIPRAZOLE ORALLY DISINTEGRATING, ARIPIPRAZOLE, ARIPIPRAZOLE ORAL, APIXABAN, APIXABAN, BISOPROLOL FUMARATE, BISOPROLOL FUMARATE, BISOPROLOL FUMARATE, BISOPROLOL FUMARATE, BISOPROLOL FUMARATE, CANDESARTAN, CANDESARTAN, CANDESARTAN, CANDESARTAN, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, ISOSORBIDE MONONITRATE, ISOSORBIDE MONONITRATE, ISOSORBIDE MONONITRATE, SIMVASTATIN, SIMVASTATIN, DAPAGLIFLOZIN, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, DIGOXIN, DIGOXIN, DIGOXIN, DIGOXIN, DIGOXIN, DIGOXIN, DIGOXIN, HYDROCHLOROTHIAZIDE, HYDROCHLOROTHIAZIDE, HYDROCHLOROTHIAZIDE, ISOSORBIDE DINITRATE, LANSOPRAZOLE, LANSOPRAZOLE, LANSOPRAZOLE, LANSOPRAZOLE, LANSOPRAZOLE, LANSOPRAZOLE, LANSOPRAZOLE, LANSOPRAZOLE, LEVOTHYROXINE SODIUM, LEVOTHYROXINE SODIUM ANHYDROUS, LEVOTHYROXINE SODIUM, LEVOTHYROXINE SODIUM ANHYDROUS, LEVOTHYROXINE SODIUM, LEVOTHYROXINE SODIUM ANHYDROUS, LEVOTHYROXINE SODIUM, LEVOTHYROXINE SODIUM ANHYDROUS, LEVOTHYROXINE SODIUM, LEVOTHYROXINE SODIUM ANHYDROUS, LEVOTHYROXINE SODIUM, LEVOTHYROXINE SODIUM ANHYDROUS, LEVOTHYROXINE SODIUM, LEVOTHYROXINE SODIUM ANHYDROUS, LEVOTHYROXINE SODIUM, LEVOTHYROXINE SODIUM ANHYDROUS, LEVOTHYROXINE SODIUM, LEVOTHYROXINE SODIUM ANHYDROUS, LEVOTHYROXINE SODIUM, LEVOTHYROXINE SODIUM ANHYDROUS, LEVOTHYROXINE SODIUM, LEVOTHYROXINE SODIUM ANHYDROUS, LEVOTHYROXINE SODIUM, LEVOTHYROXINE SODIUM ANHYDROUS, LEVOTHYROXINE SODIUM, LEVOTHYROXINE SODIUM ANHYDROUS, LEVOTHYROXINE SODIUM, LEVOTHYROXINE SODIUM ANHYDROUS, LINAGLIPTIN, LINAGLIPTIN, LINAGLIPTIN, LINAGLIPTIN, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, CANDESARTAN CILEXETIL, FELODIPINE, FELODIPINE EXTENDED-RELEASE TABLETS, SIMVASTATIN, NAPROXEN, NAPROXEN SODIUM, AMITRIPTYLINE HYDROCHLORIDE, ESTRIOL, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, SIMVASTATIN, INSULIN GLARGINE, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, BUMETANIDE, BISOPROLOL FUMARATE, BISOPROLOL FUMARATE, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, |
||||
| 38 | 25487411 |
US |
71 | 1 |
COVID-19, Cough, |
||||
LENALIDOMIDE, |
||||
| 39 | 25487800 |
ES |
76 | 1 |
Enteritis, COVID-19, |
||||
OXALIPLATIN, FLUOROURACIL CREAM, 0.5%, FLUOROURACIL, BEVACIZUMAB-AWWB, |
||||
| 40 | 25488029 |
AU |
73 | 1 |
COVID-19, |
||||
CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, FLUDARABINE PHOSPHATE, SULFAMETHOXAZOLE AND TRIMETHOPRIM, PANTOPRAZOLE, VALACYCLOVIR, VALACYCLOVIR HYDROCHLORIDE, |
||||
| 41 | 25488180 |
US |
61 | 2 |
Peripheral swelling, Pain in extremity, Skin discolouration, Lymphatic disorder, Hospitalisation, Fatigue, Asthenia, Loss of personal independence in daily activities, Influenza like illness, Fall, Condition aggravated, Urinary tract infection, Vomiting, Gait inability, Hypotonia, COVID-19, Diarrhoea, |
||||
CLADRIBINE, |
||||
| 42 | 25488533 |
GB |
54 | 2 |
Lower respiratory tract infection, Pharyngitis, Ear infection, Influenza like illness, Infection, COVID-19, Malaise, Urinary tract infection, Inappropriate schedule of product administration, |
||||
OFATUMUMAB, OFATUMUMAB, OFATUMUMAB, |
||||
| 43 | 25488671 |
CA |
79 | 2 |
COVID-19, Off label use, |
||||
UPADACITINIB, UPADACITINIB, |
||||
| 44 | 25488952 |
US |
38 | 1 |
COVID-19, |
||||
RITUXIMAB, ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, APREMILAST, PREDNISONE, COLCHICINE, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL HYDROCHLORIDE, CANAKINUMAB, UPADACITINIB, |
||||
| 45 | 25489101 |
DE |
2 | |
Fibromyalgia, Diarrhoea, Gastrointestinal infection, Gastrooesophageal reflux disease, COVID-19, Osteoarthritis, Duodenitis, Influenza like illness, Meniscus injury, Hip deformity, Road traffic accident, Eye inflammation, Pain, Cough, Rotator cuff syndrome, Hiatus hernia, Nasopharyngitis, Plantar fasciitis, Psoriatic arthropathy, |
||||
METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, SECUKINUMAB, MIRTAZAPINE, |
||||
| 46 | 25489302 |
US |
65 | 2 |
COVID-19, Visual impairment, |
||||
INSULIN GLARGINE, |
||||
| 47 | 25489815 |
US |
63 | 2 |
Oropharyngeal pain, Migraine, Type 2 diabetes mellitus, Hordeolum, Incorrect drug administration rate, Palpitations, Muscle spasms, Headache, Fatigue, Nausea, COVID-19, Insurance issue, Product dose omission issue, Depressed mood, Infusion related reaction, |
||||
HUMAN IMMUNOGLOBULIN G, HUMAN IMMUNOGLOBULIN G, |
||||
| 48 | 25489833 |
US |
2 | |
Sinusitis, COVID-19, Platelet count decreased, Product dose omission issue, |
||||
OLUTASIDENIB, |
||||
| 49 | 25490483 |
JP |
2 | |
COVID-19, |
||||
TOCILIZUMAB, |
||||
| 50 | 25494006 |
37 | 1 | |
COVID-19, |
||||
DALFAMPRIDINE, OCRELIZUMAB, |
||||
| 51 | 25481211 |
JP |
70 | 1 |
COVID-19, |
||||
TOCILIZUMAB, PREDNISOLONE, PREDNISOLONE ORAL, PREDNISOLONE ORAL SOLUTION, |
||||
| 52 | 25481232 |
CO |
64 | 1 |
COVID-19, Fracture, Fall, |
||||
TACROLIMUS, TACROLIMUS OINTMENT 0.1%, TACROLIMUS EXTENDED-RELEASE CAPSULES, |
||||
| 53 | 25481463 |
CA |
2 | |
Root canal infection, Tooth abscess, Facial pain, Neck pain, COVID-19, Gastroenteritis, Illness, |
||||
UPADACITINIB, |
||||
| 54 | 25481632 |
JP |
8 | 1 |
COVID-19, |
||||
POLATUZUMAB VEDOTIN, POLATUZUMAB VEDOTIN, |
||||
| 55 | 25481688 |
IN |
45 | 1 |
Immunosuppressant drug level increased, Fungal infection, Sepsis, COVID-19, |
||||
TACROLIMUS, TACROLIMUS OINTMENT 0.1%, TACROLIMUS EXTENDED-RELEASE CAPSULES, |
||||
| 56 | 25481922 |
IN |
45 | 1 |
Immunosuppressant drug level increased, COVID-19, Fungal infection, Sepsis, |
||||
TACROLIMUS, TACROLIMUS OINTMENT 0.1%, TACROLIMUS EXTENDED-RELEASE CAPSULES, |
||||
| 57 | 25481983 |
US |
1 | |
COVID-19, |
||||
CILTACABTAGENE AUTOLEUCEL, |
||||
| 58 | 25482230 |
GB |
54 | 1 |
Trigeminal neuralgia, Amnesia, Blindness, Brain fog, Gait disturbance, Confusional state, Suicidal ideation, Mouth swelling, Mental impairment, Pain in extremity, Photophobia, Lip swelling, Spinal pain, Tinnitus, Electric shock sensation, Dizziness, Nausea, Somnolence, Facial pain, Headache, Lethargy, Neuropathy peripheral, Depression, Feeling of despair, Toothache, COVID-19, Urinary bladder haemorrhage, Haematological infection, Dyspnoea, Urinary tract infection, Hepatic function abnormal, Hyponatraemia, Pyrexia, Hypothyroidism, White blood cell disorder, Immunosuppression, Punctate keratitis, Hypoaesthesia, Rash vesicular, Carpal tunnel syndrome, Dry eye, Anxiety, Flushing, Paraesthesia, Cough, Chest pain, Influenza like illness, |
||||
PREGABALIN, PREGABALIN, PREGABALIN, PREGABALIN, PREGABALIN, PREGABALIN, PREDNISOLONE, PREDNISOLONE ORAL, PREDNISOLONE ORAL SOLUTION, PREDNISOLONE, PREDNISOLONE ORAL, PREDNISOLONE ORAL SOLUTION, PREDNISOLONE, PREDNISOLONE ORAL, PREDNISOLONE ORAL SOLUTION, OXCARBAZEPINE, EPTINEZUMAB-JJMR, OXYCODONE HYDROCHLORIDE, OXYCODONE, CARBAMAZEPINE, CARBAMAZEPINE, BACLOFEN, BACLOFEN, PHENYTOIN, PHENYTOIN, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, LAMOTRIGINE, LAMOTRIGINE EXTENDED-RELEASE, LAMOTRIGINE CHEWABLE DISPERSIBLE, LAMOTIRIGINE, LAMOTRIGINE, LAMOTRIGINE EXTENDED-RELEASE, LAMOTRIGINE CHEWABLE DISPERSIBLE, LAMOTIRIGINE, LAMOTRIGINE, LAMOTRIGINE EXTENDED-RELEASE, LAMOTRIGINE CHEWABLE DISPERSIBLE, LAMOTIRIGINE, LAMOTRIGINE, LAMOTRIGINE EXTENDED-RELEASE, LAMOTRIGINE CHEWABLE DISPERSIBLE, LAMOTIRIGINE, LAMOTRIGINE, LAMOTRIGINE EXTENDED-RELEASE, LAMOTRIGINE CHEWABLE DISPERSIBLE, LAMOTIRIGINE, LAMOTRIGINE, LAMOTRIGINE EXTENDED-RELEASE, LAMOTRIGINE CHEWABLE DISPERSIBLE, LAMOTIRIGINE, LAMOTRIGINE, LAMOTRIGINE EXTENDED-RELEASE, LAMOTRIGINE CHEWABLE DISPERSIBLE, LAMOTIRIGINE, LAMOTRIGINE, LAMOTRIGINE EXTENDED-RELEASE, LAMOTRIGINE CHEWABLE DISPERSIBLE, LAMOTIRIGINE, MIRTAZAPINE, BUPRENORPHINE, NALTREXONE, NAPROXEN, NAPROXEN SODIUM, ONDANSETRON HYDROCHLORIDE, ONDANSETRON, ONDANSETRON TABLETS, LACOSAMIDE, LACOSAMIDE, LACOSAMIDE, LACOSAMIDE, LACOSAMIDE, DIAZEPAM, DIAZEPAM ORAL, DIAZEPAM ORAL SOLUTION (CONCENTRATE), DULOXETINE HYDROCHLORIDE, DULOXETINE, ACYCLOVIR, LIDOCAINE, LIDOCAINE HYDROCHLORIDE, BURN RELIEF, MAXIMUM STRENGTH PAIN RELIEVER, LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE BITARTRATE, LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE, LIDOCAINE 4%, LIDOCAINE, MENTHOL, LIDOCAINE, LIDOCAINE HYDROCHLORIDE, BURN RELIEF, MAXIMUM STRENGTH PAIN RELIEVER, LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE BITARTRATE, LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE, LIDOCAINE 4%, LIDOCAINE, MENTHOL, MAGNESIUM, GABAPENTIN, GABAPENTIN, GABAPENTIN, |
||||
| 59 | 25482376 |
US |
40 | |
COVID-19, |
||||
TOLVAPTAN, TOLVAPTAN, |
||||
| 60 | 25482686 |
GB |
||
COVID-19, Neuropathy peripheral, Feeling of despair, Toothache, Urinary tract infection, Hepatic function abnormal, Electric shock sensation, Tinnitus, Mental impairment, Immunosuppression, Hypothyroidism, White blood cell disorder, Photophobia, Spinal pain, Urinary bladder haemorrhage, Trigeminal neuralgia, Haematological infection, Hyponatraemia, Gait disturbance, Brain fog, Punctate keratitis, Blindness, Facial pain, Pyrexia, Dizziness, Nausea, Lip swelling, Pain in extremity, Amnesia, Headache, Depression, Suicidal ideation, Mouth swelling, Dyspnoea, Lethargy, Somnolence, Confusional state, Cough, Chest pain, Rash vesicular, Carpal tunnel syndrome, Flushing, Influenza like illness, Anxiety, Dry eye, Paraesthesia, Hypoaesthesia, |
||||
PREGABALIN, PREGABALIN, PREGABALIN, PREGABALIN, PREGABALIN, PREGABALIN, OXCARBAZEPINE, OXYCODONE HYDROCHLORIDE, OXYCODONE, PREDNISOLONE, PREDNISOLONE ORAL, PREDNISOLONE ORAL SOLUTION, PREDNISOLONE, PREDNISOLONE ORAL, PREDNISOLONE ORAL SOLUTION, PREDNISOLONE, PREDNISOLONE ORAL, PREDNISOLONE ORAL SOLUTION, EPTINEZUMAB-JJMR, CARBAMAZEPINE, CARBAMAZEPINE, BACLOFEN, BACLOFEN, PHENYTOIN, PHENYTOIN, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, LAMOTRIGINE, LAMOTRIGINE EXTENDED-RELEASE, LAMOTRIGINE CHEWABLE DISPERSIBLE, LAMOTIRIGINE, LAMOTRIGINE, LAMOTRIGINE EXTENDED-RELEASE, LAMOTRIGINE CHEWABLE DISPERSIBLE, LAMOTIRIGINE, LAMOTRIGINE, LAMOTRIGINE EXTENDED-RELEASE, LAMOTRIGINE CHEWABLE DISPERSIBLE, LAMOTIRIGINE, LAMOTRIGINE, LAMOTRIGINE EXTENDED-RELEASE, LAMOTRIGINE CHEWABLE DISPERSIBLE, LAMOTIRIGINE, LAMOTRIGINE, LAMOTRIGINE EXTENDED-RELEASE, LAMOTRIGINE CHEWABLE DISPERSIBLE, LAMOTIRIGINE, LAMOTRIGINE, LAMOTRIGINE EXTENDED-RELEASE, LAMOTRIGINE CHEWABLE DISPERSIBLE, LAMOTIRIGINE, LAMOTRIGINE, LAMOTRIGINE EXTENDED-RELEASE, LAMOTRIGINE CHEWABLE DISPERSIBLE, LAMOTIRIGINE, LAMOTRIGINE, LAMOTRIGINE EXTENDED-RELEASE, LAMOTRIGINE CHEWABLE DISPERSIBLE, LAMOTIRIGINE, MIRTAZAPINE, BUPRENORPHINE, NALTREXONE, NAPROXEN, NAPROXEN SODIUM, ONDANSETRON HYDROCHLORIDE, ONDANSETRON, ONDANSETRON TABLETS, LACOSAMIDE, LACOSAMIDE, LACOSAMIDE, LACOSAMIDE, LACOSAMIDE, DIAZEPAM, DIAZEPAM ORAL, DIAZEPAM ORAL SOLUTION (CONCENTRATE), DULOXETINE HYDROCHLORIDE, DULOXETINE, DULOXETINE HYDROCHLORIDE, DULOXETINE, ACYCLOVIR, ONABOTULINUMTOXINA, LIDOCAINE, LIDOCAINE HYDROCHLORIDE, BURN RELIEF, MAXIMUM STRENGTH PAIN RELIEVER, LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE BITARTRATE, LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE, LIDOCAINE 4%, LIDOCAINE, MENTHOL, LIDOCAINE, LIDOCAINE HYDROCHLORIDE, BURN RELIEF, MAXIMUM STRENGTH PAIN RELIEVER, LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE BITARTRATE, LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE, LIDOCAINE 4%, LIDOCAINE, MENTHOL, MAGNESIUM, GABAPENTIN, GABAPENTIN, GABAPENTIN, |
||||
| 61 | 25482747 |
TW |
44 | 1 |
Cardiac arrest, Disseminated intravascular coagulation, COVID-19, Respiratory failure, Metabolic acidosis, Lactic acidosis, Renal failure, Hyperkalaemia, Arrhythmia, Hepatic failure, Tumour lysis syndrome, Sepsis, Pancytopenia, Dyspnoea, Febrile neutropenia, |
||||
PONATINIB HYDROCHLORIDE, PONATINIB HYDROCHLORIDE, DASATINIB, NILOTINIB, |
||||
| 62 | 25483333 |
US |
68 | 2 |
COVID-19, Disease recurrence, |
||||
NIRMATRELVIR AND RITONAVIR, |
||||
| 63 | 25483436 |
US |
2 | |
Vein rupture, COVID-19, Pulmonary embolism, Pneumonia, Dizziness, Gastroenteritis viral, Malaise, Diarrhoea, Peripheral swelling, Asthenia, Abdominal pain upper, Muscular weakness, Nausea, Petechiae, Increased tendency to bruise, Seasonal allergy, Thoracic vertebral fracture, |
||||
NINTEDANIB, |
||||
| 64 | 25483537 |
CA |
66 | 2 |
Product prescribing error, Drug ineffective, Influenza, Wrong technique in product usage process, SARS-CoV-2 test positive, Off label use, Platelet count decreased, COVID-19, Mouth haemorrhage, Platelet count increased, Fatigue, Drug interaction, |
||||
METHOTREXATE, METHOTREXATE SODIUM, ELTROMBOPAG OLAMINE, ELTROMBOPAG OLAMINE, ELTROMBOPAG OLAMINE, ELTROMBOPAG OLAMINE, ELTROMBOPAG OLAMINE, ELTROMBOPAG OLAMINE, ELTROMBOPAG OLAMINE, ELTROMBOPAG OLAMINE, ELTROMBOPAG OLAMINE, PREDNISONE, DEXAMETHASONE, DEXAMETHASONE 1.5 MG, RITUXIMAB, |
||||
| 65 | 25483719 |
DE |
2 | |
Psoriatic arthropathy, Diarrhoea, Rotator cuff syndrome, Influenza like illness, Hip deformity, COVID-19, Gastrointestinal infection, Osteoarthritis, Nasopharyngitis, Eye inflammation, Cough, Meniscus injury, Plantar fasciitis, |
||||
METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, SECUKINUMAB, MIRTAZAPINE, |
||||
| 66 | 25483753 |
CO |
27 | 1 |
Respiratory symptom, Bacterial infection, Bronchitis, COVID-19, |
||||
TACROLIMUS, TACROLIMUS OINTMENT 0.1%, TACROLIMUS EXTENDED-RELEASE CAPSULES, |
||||
| 67 | 25484888 |
IT |
72 | 1 |
COVID-19, |
||||
CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, FLUDARABINE PHOSPHATE, FLUDARABINE PHOSPHATE, IBRUTINIB, IBRUTINIB, RITUXIMAB, RITUXIMAB, VENETOCLAX, VENETOCLAX, |
||||
| 68 | 25485027 |
NL |
||
COVID-19, |
||||
BACLOFEN, |
||||
| 69 | 25485345 |
US |
83 | 2 |
Cellulitis, Breast cancer female, Pulmonary thrombosis, Syncope, Renal disorder, Fall, Skin laceration, Arthritis, Urinary tract infection, Cystitis, Ear infection, Sinus disorder, Seasonal allergy, COVID-19, Wrong technique in device usage process, Inappropriate schedule of product administration, Weight decreased, Product use issue, Product dose omission issue, Infusion site haemorrhage, Sinusitis, Vertigo, Oropharyngeal pain, Pain, Infusion site pain, Dizziness, Nausea, |
||||
HUMAN IMMUNOGLOBULIN G, HUMAN IMMUNOGLOBULIN G, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, DIPHENHYDRAMINE, DIPHENHYDRAMINE HYDROCHLORIDE, EPINEPHRINE, ADRENALINUM, LIDOCAINE, GABAPENTIN, MELOXICAM, MONTELUKAST SODIUM, MEDROXYPROGESTERONE ACETATE, AZELASTINE HYDROCHLORIDE AND FLUTICASONE PROPIONATE, CONJUGATED ESTROGENS, ESTROGENS, CONJUGATED, ATORVASTATIN CALCIUM, MELATONIN, CLONAZEPAM, HYDROCHLOROTHIAZIDE, AMITRIPTYLINE HYDROCHLORIDE, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, LEVOTHYROXINE SODIUM, RANITIDINE HYDROCHLORIDE, THIAMINE HYDROCHLORIDE, ERGOCALCIFEROL, PAROXETINE HYDROCHLORIDE, FISH OIL, DEXLANSOPRAZOLE, MAGNESIUM, OMEPRAZOLE MAGNESIUM, MONTELUKAST SODIUM, MONTELUKAST, ATORVASTATIN CALCIUM, ATORVASTATIN CALCIUM, FILM COATED, OXAPROZIN, THIAMINE HYDROCHLORIDE, LIDOCAINE, LIDOCAINE HYDROCHLORIDE, BURN RELIEF, MAXIMUM STRENGTH PAIN RELIEVER, LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE BITARTRATE, LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE, LIDOCAINE 4%, LIDOCAINE, MENTHOL, DIPHENHYDRAMINE HYDROCHLORIDE, DIPHENHYDRAMINE HYDROCHLORIDE CAPSULE, LIQUID FILLED, EXEMESTANE, FAMOTIDINE, DEXLANSOPRAZOLE, QUETIAPINE FUMARATE, QUETIAPINE, EMPAGLIFLOZIN, ALCLOMETASONE DIPROPIONATE, |
||||
| 70 | 25485425 |
US |
82 | 1 |
Knee arthroplasty, Musculoskeletal stiffness, Neoplasm skin, Contusion, Depression, Diarrhoea, Haemorrhage subcutaneous, Food poisoning, Back disorder, Arthralgia, COVID-19, Pollakiuria, Back pain, Oedema peripheral, Product dose omission issue, Product dose omission in error, |
||||
NIRMATRELVIR AND RITONAVIR, |
||||
| 71 | 25485453 |
CA |
39 | 2 |
Abdominal pain, COVID-19, Crohn^s disease, Drug ineffective, Fatigue, General physical health deterioration, Haematochezia, Hypersensitivity, Pain, |
||||
RITUXIMAB, ADALIMUMAB-ADAZ, ADALIMUMAB-ADAZ, CLONAZEPAM, INFLIXIMAB-DYYB, MINOCYCLINE, PREDNISONE, QUETIAPINE FUMARATE, QUETIAPINE, |
||||
| 72 | 25485457 |
ES |
76 | 1 |
Enteritis, COVID-19, |
||||
IRINOTECAN HYDROCHLORIDE, FLUOROURACIL CREAM, 0.5%, FLUOROURACIL, OXALIPLATIN, BEVACIZUMAB-AWWB, |
||||
| 73 | 25485550 |
TH |
84 | 1 |
Death, COVID-19, Fall, Cerebral haemorrhage, |
||||
PEMBROLIZUMAB, |
||||
| 74 | 25485569 |
CO |
38 | 2 |
COVID-19, Immunosuppressant drug level increased, |
||||
TACROLIMUS, TACROLIMUS OINTMENT 0.1%, TACROLIMUS EXTENDED-RELEASE CAPSULES, TACROLIMUS, TACROLIMUS OINTMENT 0.1%, TACROLIMUS EXTENDED-RELEASE CAPSULES, MYCOPHENOLIC ACID, MYCOPHENILIC ACID, |
||||
| 75 | 25485659 |
CO |
2 | |
Death, Renal failure, COVID-19, Swelling, Weight decreased, Anaemia, Pneumonia, Diabetes mellitus, Decreased appetite, |
||||
TACROLIMUS, TACROLIMUS OINTMENT 0.1%, TACROLIMUS EXTENDED-RELEASE CAPSULES, |
||||
| 76 | 25475966 |
ES |
||
Acute respiratory failure, COVID-19, Proteus infection, |
||||
ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, |
||||
| 77 | 25476341 |
US |
2 | |
Rectal haemorrhage, COVID-19, Gastrointestinal pain, Headache, Constipation, Diarrhoea, Flatulence, Gastrooesophageal reflux disease, Abdominal pain upper, |
||||
SEMAGLUTIDE, |
||||
| 78 | 25476584 |
IN |
45 | 1 |
Immunosuppressant drug level increased, COVID-19, Fungal infection, Sepsis, |
||||
TACROLIMUS, TACROLIMUS OINTMENT 0.1%, TACROLIMUS EXTENDED-RELEASE CAPSULES, |
||||
| 79 | 25476626 |
CA |
61 | 1 |
Thrombosis, Pneumonia, Cytomegalovirus infection, COVID-19, Influenza, |
||||
INFLIXIMAB, INFLIXIMAB, |
||||
| 80 | 25476771 |
IT |
89 | 2 |
COVID-19, Pneumothorax, Dyspnoea, Pneumomediastinum, Chest pain, Subcutaneous emphysema, Off label use, Drug interaction, Product use in unapproved indication, |
||||
AZITHROMYCIN, AZITHROMYCIN MONOHYDRATE, AZITHROMYCIN DIHYDRATE, AZITHROMYCIN, AZITHROMYCIN MONOHYDRATE, AZITHROMYCIN DIHYDRATE, HYDROXYCHLOROQUINE, METHYLPREDNISOLONE, ACETYLCYSTEINE, |
||||
| 81 | 25477009 |
US |
61 | 2 |
COVID-19, Malaise, |
||||
TOCILIZUMAB, DUPILUMAB, DUPILUMAB, DUPILUMAB, |
||||
| 82 | 25477573 |
AU |
72 | 2 |
Toxicity to various agents, Acute kidney injury, Escherichia urinary tract infection, COVID-19, Diarrhoea, Nausea, Vomiting, Drug interaction, |
||||
TACROLIMUS, TACROLIMUS OINTMENT 0.1%, TACROLIMUS EXTENDED-RELEASE CAPSULES, TACROLIMUS, TACROLIMUS OINTMENT 0.1%, TACROLIMUS EXTENDED-RELEASE CAPSULES, NIRMATRELVIR AND RITONAVIR, APIXABAN, METFORMIN HYDROCHLORIDE, METFORMIN, METFORMIN HYDROCHLORIDE EXTENDED-RELEASE TABLETS, METFORMIN HYDROCHLORIDE TABLET, METFORMIN HYDROCHLORIDE TABLETS, MYCOPHENOLIC ACID, MYCOPHENILIC ACID, PREDNISONE, RABEPRAZOLE SODIUM, RABEPRAZOLE, SIMVASTATIN, SOTALOL HYDROCHLORIDE, SOTALOL HYDROCHLORIDE TABLES AF, SOTALOL HYDROCHLORIDE TABLETS AF, |
||||
| 83 | 25477827 |
GB |
2 | |
Multiple sclerosis, Abdominal discomfort, Constipation, Haemorrhoids, Fatigue, Influenza, COVID-19, Band sensation, |
||||
OFATUMUMAB, OFATUMUMAB, |
||||
| 84 | 25478521 |
JP |
71 | |
Colon cancer, Carcinoembryonic antigen increased, COVID-19, |
||||
DURVALUMAB, DURVALUMAB, TREMELIMUMAB, TREMELIMUMAB, CARBOPLATIN, PACLITAXEL, |
||||
| 85 | 25478565 |
27 | 2 | |
COVID-19, Haemophagocytic lymphohistiocytosis, Cardiomyopathy, |
||||
METHOTREXATE, METHOTREXATE SODIUM, |
||||
| 86 | 25478853 |
IT |
58 | 1 |
Capillary leak syndrome, COVID-19, |
||||
AMLODIPINE BESYLATE AND OLMESARTAN MEDOXOMIL, |
||||
| 87 | 25478953 |
US |
69 | 1 |
COVID-19, Disease recurrence, |
||||
NIRMATRELVIR AND RITONAVIR, |
||||
| 88 | 25479012 |
US |
||
COVID-19, |
||||
RAVULIZUMAB, |
||||
| 89 | 25479215 |
CA |
80 | 2 |
Angioplasty, Arthralgia, Arthritis, Back pain, COVID-19, Drug ineffective, Ear pain, Eating disorder, Facial pain, Frequent bowel movements, Gastric haemorrhage, General physical health deterioration, Injection site bruising, Injury, Insomnia, Malaise, Nasal discharge discolouration, Nausea, Oral herpes, Osteoporosis, Pain, Pain assessment, Pain in extremity, Pain in jaw, Pneumonia, Psoriasis, Sinusitis, Suture removal, Syncope, Toe amputation, Toothache, Visual impairment, Vomiting, Weight decreased, Wrong technique in product usage process, Abdominal pain, |
||||
MORPHINE SULFATE, CLOPIDOGREL, CLOPIDOGREL BISULFATE, AMBRISENTAN, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, HYDROMORPHONE HYDROCHLORIDE, PREGABALIN, |
||||
| 90 | 25479396 |
GB |
27 | 2 |
Haemophagocytic lymphohistiocytosis, Cardiomyopathy, COVID-19, |
||||
METHOTREXATE, METHOTREXATE SODIUM, |
||||
| 91 | 25470383 |
NL |
73 | 1 |
Hepatic failure, COVID-19, |
||||
LENALIDOMIDE, TALQUETAMAB, BISOPROLOL FUMARATE, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, CALCIUM CARBONATE, ANTACID, DARBEPOETIN ALFA, ELTROMBOPAG OLAMINE, ELTROMBOPAG, CEFTRIAXONE, CEFTRIAXONE SODIUM, NIRMATRELVIR AND RITONAVIR, CHOLESTYRAMINE, CHOLESTYRAMINE, INSULIN GLARGINE-YFGN, INSULIN GLARGINE, INSULIN ASPART, METFORMIN HYDROCHLORIDE, METFORMIN, METFORMIN HYDROCHLORIDE EXTENDED-RELEASE TABLETS, METFORMIN HYDROCHLORIDE TABLET, METFORMIN HYDROCHLORIDE TABLETS, PANTOPRAZOLE, VALACYCLOVIR HYDROCHLORIDE, VALACYCLOVIR, DEXAMETHASONE, DEXAMETHASONE 1.5 MG, CLOPIDOGREL, CLOPIDOGREL BISULFATE, CLINDAMYCIN PHOSPHATE, CLINDAMYCIN, BUMETANIDE, |
||||
| 92 | 25470404 |
AU |
||
Acute myocardial infarction, COVID-19, Headache, Hypotension, Oedema peripheral, |
||||
AMLODIPINE BESYLATE, TELMISARTAN, |
||||
| 93 | 25470465 |
DK |
75 | 1 |
Off label use, COVID-19, Humoral immune defect, |
||||
IBRUTINIB, BENDAMUSTINE HCL, RITUXIMAB, RITUXIMAB, CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, FLUDARABINE PHOSPHATE, REMDESIVIR, DEXAMETHASONE, DEXAMETHASONE 1.5 MG, |
||||
| 94 | 25470566 |
AU |
45 | 2 |
COVID-19, Multiple sclerosis relapse, Hemiparesis, Peroneal nerve palsy, |
||||
OCRELIZUMAB, DALFAMPRIDINE, AMANTADINE HYDROCHLORIDE, |
||||
| 95 | 25471141 |
US |
5 | 2 |
Intestinal pseudo-obstruction, Diarrhoea, Sinus disorder, Viral infection, Food intolerance, Gastrointestinal disorder, Weight decreased, Abdominal discomfort, Multiple allergies, Gastrointestinal stoma output abnormal, Hyperphagia, Weight increased, Pallor, Hypophagia, Product distribution issue, Product dose omission issue, Diversion colitis, Ear disorder, Lactase deficiency, Nocturia, Illness, Rhinovirus infection, Gastrointestinal infection, COVID-19, Appetite disorder, Injection site pain, Nausea, Nasopharyngitis, Decreased appetite, Cough, Vomiting, Gastrointestinal stoma complication, Abdominal pain, |
||||
TEDUGLUTIDE, TEDUGLUTIDE, TEDUGLUTIDE, TEDUGLUTIDE, TEDUGLUTIDE, TEDUGLUTIDE, TEDUGLUTIDE, TEDUGLUTIDE, TEDUGLUTIDE, TEDUGLUTIDE, TEDUGLUTIDE, TEDUGLUTIDE, SMOFLIPID, METRONIDAZOLE, METRONIDAZOLE TOPICAL, METRONIDAZOLE, CETIRIZINE HCL, CETIRIZINE, SCOPOLAMINE, FLUTICASONE PROPIONATE, NYSTATIN, NYSTATIN OINTMENT, NYSTATIN CREAM, CYPROHEPTADINE HYDROCHLORIDE, ERYTHROMYCIN ETHYLSUCCINATE, ERYTHROMYCIN, ONDANSETRON HYDROCHLORIDE, ONDANSETRON, ONDANSETRON TABLETS, FAMOTIDINE, MULTIPLE VITAMINS INJECTION, SODIUM CHLORIDE, SODIUM CHLORIDE INJECTION, SODIUM CHLORIDE TABLET, HYOSCYAMINE SULFATE, SULFASALAZINE, MONTELUKAST SODIUM, GUAIFENESIN, ESOMEPRAZOLE MAGNESIUM, ESOMEPRAZOLE, ESOMEPRAZOLE MAGNESIUM CAPSULE, DELAYED RELEASE, ESOMEPRAZOLE MAGNESIUM DELAYED RELEASE CAPSULES, RIFAMPIN, |
||||
| 96 | 25471264 |
US |
48 | 2 |
Joint swelling, Arthralgia, COVID-19, |
||||
ABATACEPT, |
||||
| 97 | 25471636 |
CA |
64 | 1 |
Cystitis, COVID-19, Off label use, Herpes zoster, |
||||
METHOTREXATE SODIUM, ADALIMUMAB, |
||||
| 98 | 25471935 |
GB |
||
Urinary bladder haemorrhage, Trigeminal neuralgia, Blindness, Mental impairment, Lethargy, COVID-19, Feeling of despair, Toothache, Electric shock sensation, Tinnitus, Hypothyroidism, Punctate keratitis, Mouth swelling, Pain in extremity, Brain fog, Lip swelling, Gait disturbance, Spinal pain, Photophobia, Pyrexia, White blood cell disorder, Haematological infection, Hepatic function abnormal, Urinary tract infection, Dyspnoea, Facial pain, Hyponatraemia, Somnolence, Neuropathy peripheral, Confusional state, Suicidal ideation, Headache, Immunosuppression, Depression, Amnesia, Dizziness, Nausea, Rash vesicular, Carpal tunnel syndrome, Chest pain, Cough, Paraesthesia, Dry eye, Hypoaesthesia, Influenza like illness, Flushing, Anxiety, |
||||
PREDNISOLONE, PREDNISOLONE ORAL, PREDNISOLONE ORAL SOLUTION, PREDNISOLONE, PREDNISOLONE ORAL, PREDNISOLONE ORAL SOLUTION, PREDNISOLONE, PREDNISOLONE ORAL, PREDNISOLONE ORAL SOLUTION, PREGABALIN, PREGABALIN, PREGABALIN, PREGABALIN, PREGABALIN, PREGABALIN, OXCARBAZEPINE, OXYCODONE HYDROCHLORIDE, OXYCODONE, EPTINEZUMAB-JJMR, CARBAMAZEPINE, CARBAMAZEPINE, BACLOFEN, BACLOFEN, PHENYTOIN, PHENYTOIN, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, LAMOTRIGINE, LAMOTRIGINE EXTENDED-RELEASE, LAMOTRIGINE CHEWABLE DISPERSIBLE, LAMOTIRIGINE, LAMOTRIGINE, LAMOTRIGINE EXTENDED-RELEASE, LAMOTRIGINE CHEWABLE DISPERSIBLE, LAMOTIRIGINE, LAMOTRIGINE, LAMOTRIGINE EXTENDED-RELEASE, LAMOTRIGINE CHEWABLE DISPERSIBLE, LAMOTIRIGINE, LAMOTRIGINE, LAMOTRIGINE EXTENDED-RELEASE, LAMOTRIGINE CHEWABLE DISPERSIBLE, LAMOTIRIGINE, LAMOTRIGINE, LAMOTRIGINE EXTENDED-RELEASE, LAMOTRIGINE CHEWABLE DISPERSIBLE, LAMOTIRIGINE, LAMOTRIGINE, LAMOTRIGINE EXTENDED-RELEASE, LAMOTRIGINE CHEWABLE DISPERSIBLE, LAMOTIRIGINE, LAMOTRIGINE, LAMOTRIGINE EXTENDED-RELEASE, LAMOTRIGINE CHEWABLE DISPERSIBLE, LAMOTIRIGINE, LAMOTRIGINE, LAMOTRIGINE EXTENDED-RELEASE, LAMOTRIGINE CHEWABLE DISPERSIBLE, LAMOTIRIGINE, MIRTAZAPINE, BUPRENORPHINE, NALTREXONE, NAPROXEN, NAPROXEN SODIUM, ONDANSETRON HYDROCHLORIDE, ONDANSETRON, ONDANSETRON TABLETS, LACOSAMIDE, LACOSAMIDE, LACOSAMIDE, LACOSAMIDE, LACOSAMIDE, DIAZEPAM, DIAZEPAM ORAL, DIAZEPAM ORAL SOLUTION (CONCENTRATE), DULOXETINE HYDROCHLORIDE, DULOXETINE, DULOXETINE HYDROCHLORIDE, DULOXETINE, ACYCLOVIR, ONABOTULINUMTOXINA, LIDOCAINE, LIDOCAINE HYDROCHLORIDE, BURN RELIEF, MAXIMUM STRENGTH PAIN RELIEVER, LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE BITARTRATE, LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE, LIDOCAINE 4%, LIDOCAINE, MENTHOL, LIDOCAINE, LIDOCAINE HYDROCHLORIDE, BURN RELIEF, MAXIMUM STRENGTH PAIN RELIEVER, LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE BITARTRATE, LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE, LIDOCAINE 4%, LIDOCAINE, MENTHOL, MAGNESIUM, GABAPENTIN, GABAPENTIN, GABAPENTIN, |
||||
| 99 | 25472182 |
US |
66 | 1 |
Mechanical ventilation, COVID-19, |
||||
REMDESIVIR, |
||||
| 100 | 25472312 |
US |
63 | 2 |
COVID-19, |
||||
AVAPRITINIB, AVAPRITINIB, AVAPRITINIB, |
||||
disclaimer
Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.
terms
license
last_updated
2025-07-29